Ruben Raychaudhuri, MD

Ruben Raychaudhuri, MD

Ruben Raychaudhuri, MD | Fred Hutchinson Cancer Center

Articles by Ruben Raychaudhuri, MD

Neoadjuvant Pembrolizumab and aMVAC for Non-Urothelial MIBC: Does This Combination Improve Outcomes?

Petros Grivas, MD, PhDUrothelial Carcinoma | February 21, 2025

Drs. Grivas, Khaki, and Raychaudhuri discuss a phase II trial evaluating pembrolizumab plus aMVAC for non-UC MIBC.